Australia markets close in 4 hours 21 minutes

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.20-0.52 (-6.74%)
At close: 04:00PM EST
7.35 +0.15 (+2.08%)
After hours: 05:40PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts20152020
Avg. Estimate-0.7-0.69-2.37-2.74
Low estimate-0.84-0.8-2.5-3.1
High estimate-0.53-0.55-2.21-2.12
Year ago EPS-0.54-0.56-1.89-2.37
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts15101814
Avg. Estimate60kN/A190k3.9M
Low estimateN/AN/AN/AN/A
High estimate800k50k1M46.37M
Year ago sales51k61k38.49M190k
Sales growth (year/est)17.60%N/A-99.50%1,952.60%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.6-0.58-0.61-0.64
Actual EPS-0.54-0.56-0.52-0.58
Difference0.060.020.090.06
Surprise %10.00%3.40%14.80%9.40%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.7-0.69-2.37-2.74
7 days ago-0.7-0.69-2.37-2.74
30 days ago-0.7-0.68-2.36-2.74
60 days ago-0.7-0.69-2.37-2.77
90 days ago-0.7-0.69-2.37-2.77
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesALLOIndustrySector(s)S&P 500
Current qtr.-29.60%N/AN/AN/A
Next qtr.-23.20%N/AN/AN/A
Current year-25.40%N/AN/AN/A
Next year-15.60%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A